120 related articles for article (PubMed ID: 12450696)
1. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus.
Matsui M; Moriya O; Abdel-Aziz N; Matsuura Y; Miyamura T; Akatsuka T
Vaccine; 2002 Dec; 21(3-4):211-20. PubMed ID: 12450696
[TBL] [Abstract][Full Text] [Related]
2. Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid.
Matsui M; Moriya O; Akatsuka T
Vaccine; 2003 Apr; 21(15):1629-39. PubMed ID: 12639484
[TBL] [Abstract][Full Text] [Related]
3. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein.
Moriya O; Matsui M; Osorio M; Miyazawa H; Rice CM; Feinstone SM; Leppla SH; Keith JM; Akatsuka T
Vaccine; 2001 Dec; 20(5-6):789-96. PubMed ID: 11738742
[TBL] [Abstract][Full Text] [Related]
4. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
[TBL] [Abstract][Full Text] [Related]
5. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
Wang QC; Feng ZH; Zhou YX; Nie QH
World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
[TBL] [Abstract][Full Text] [Related]
6. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
[TBL] [Abstract][Full Text] [Related]
7. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice.
Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y
Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.
Matsui M; Moriya O; Belladonna ML; Kamiya S; Lemonnier FA; Yoshimoto T; Akatsuka T
J Virol; 2004 Sep; 78(17):9093-104. PubMed ID: 15308705
[TBL] [Abstract][Full Text] [Related]
9. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.
Arichi T; Saito T; Major ME; Belyakov IM; Shirai M; Engelhard VH; Feinstone SM; Berzofsky JA
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):297-302. PubMed ID: 10618412
[TBL] [Abstract][Full Text] [Related]
11. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
[TBL] [Abstract][Full Text] [Related]
12. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.
Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY
World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
[TBL] [Abstract][Full Text] [Related]
14. Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus.
Zhou Y; Zhao F; Chen L; Ma L; Wang Y; He Y; Ma Z; Liu H; Guo Y; Zhang Y; Yao Z; Hao C; Jia Z
Int J Mol Med; 2013 Oct; 32(4):901-9. PubMed ID: 23934073
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.
Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ
Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo.
Peng W; Zhao G; Ma Y; Yu H; Wang X
Vaccine; 2011 Apr; 29(18):3501-6. PubMed ID: 21352943
[TBL] [Abstract][Full Text] [Related]
18. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.
Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH
World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545
[TBL] [Abstract][Full Text] [Related]
20. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
